Head of Strategic Planning & Operations, Gene and Cell Therapy Institute
Meini Shin is a seasoned executive in healthcare strategic planning, finance, and operations, with over 20 years of experience driving institutional growth across leading academic medical centers. She currently serves as the Executive Director of Strategic Planning and Operations for both the Gene and Cell Therapy Institute and Personalized Medicine at Mass General Brigham, where she leads enterprise-level financial planning, strategic execution, and organizational development initiatives.
Throughout her career, Meini has been a trusted advisor to senior leadership, recognized for her ability to align complex initiatives, enhance operational efficiency, and cultivate high-performing teams. Her expertise spans financial strategy, program implementation, stakeholder engagement, and risk management across clinical, research, and administrative environments.
She holds an MBA in Finance from Boston University and a bachelor’s degree in accounting from Parahyangan Catholic University in Indonesia. A globally minded leader, Meini brings a data-driven, collaborative approach to advancing innovation and operational excellence in healthcare.
